Bausch Health to Acquire DURECT Corporation
LOCUST WALK NEWS Bausch Health to Acquire DURECT Corporation DURECT’s lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough […]
News
2025
Uncategorized
Episode 29: Asia’s 2025 Q2 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 7:34 — 17.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 29 of Biotalk, Geoff shares insights into key trends and developments shaping the biotech landscapes in
Uncategorized
Biotalk Episode 28: 2025 Q2 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 17:28 — 40.0MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 28 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q2 Report: Global Trends in Biopharma
Insight, Locust Walk Insights, Market Trends, Quarterly Reports
2025 Q2 Report: Global Trends in Biopharma Transactions
2025 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
Uncategorized
Episode 27: Inside the Biopharma Market: 2025 Outlook & Emerging Trends
Podcast: Play in new window | Download (Duration: 7:47 — 17.8MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the
Uncategorized
Episode 26: Asia’s 2025 Q1 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 10:38 — 24.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 26 of Biotalk, Geoff Meyerson, CEO of Locust Walk, shares fresh insights from Japan, China, and Korea,
Uncategorized
Biotalk Episode 25: 2025 Q1 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 13:17 — 30.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 25 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q1 Report: Global Trends in Biopharma
Insight, Locust Walk Insights, Market Trends, Quarterly Reports
2025 Q1 Report: Global Trends in Biopharma Transactions
2025 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic
Insight, Locust Walk Insights, Market Trends, Quarterly Reports
China Supermarket: Is the Value for Money Due to Global Development Expertise or Superior Negotiation?
China Supermarket: Is the Value for Money Due to Global Development Expertise or Superior Negotiation? Locust Walk analyzed the evolving
News
Sun Pharma to Acquire Checkpoint Therapeutics
LOCUST WALK NEWS Sun Pharma to Acquire Checkpoint Therapeutics Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment